scholarly journals Potential Imaging Biomarkers in the Development and Progression of Diabetic Retinopathy

Author(s):  
Julia Hafner ◽  
Sonja Karst ◽  
Ursula Schmidt-Erfurth
2020 ◽  
Vol 12 ◽  
pp. 251584142095051 ◽  
Author(s):  
Ashish Markan ◽  
Aniruddha Agarwal ◽  
Atul Arora ◽  
Krinjeela Bazgain ◽  
Vipin Rana ◽  
...  

Diabetic retinopathy is one of the major microvascular complications of diabetes mellitus. The most common causes of vision loss in diabetic retinopathy are diabetic macular edema and proliferative diabetic retinopathy. Recent developments in ocular imaging have played a significant role in early diagnosis and management of these complications. Color fundus photography is an imaging modality, which is helpful for screening patients with diabetic eye disease and monitoring its progression as well as response to treatment. Fundus fluorescein angiography (FFA) is a dye-based invasive test to detect subtle neovascularization, look for areas of capillary non-perfusion, diagnose macular ischemia, and differentiate between focal and diffuse capillary bed leak in cases of macular edema. Recent advances in retinal imaging like the introduction of spectral-domain and swept source-based optical coherence tomography (OCT), fundus autofluorescence (FAF), OCT angiography, and ultrawide field imaging and FFA have helped clinicians in the detection of certain biomarkers that can identify disease at an early stage and predict response to treatment in diabetic macular edema. This article will summarize the role of different imaging biomarkers in characterizing diabetic retinopathy and their potential contribution in its management.


2017 ◽  
Vol Volume 11 ◽  
pp. 2073-2089 ◽  
Author(s):  
Arpan Guha Mazumder ◽  
Swarnadip Chatterjee ◽  
Saunak Chatterjee ◽  
Juan Jose Gonzalez ◽  
Swarnendu Bag ◽  
...  

Endocrine ◽  
2019 ◽  
Vol 66 (3) ◽  
pp. 509-516 ◽  
Author(s):  
Sandeep Saxena ◽  
Martin Caprnda ◽  
Surabhi Ruia ◽  
Senthamizh Prasad ◽  
Ankita ◽  
...  

2021 ◽  
Vol 11 (9) ◽  
pp. 885
Author(s):  
Hannah J. Yu ◽  
Justis P. Ehlers ◽  
Duriye Damla Sevgi ◽  
Margaret O’Connell ◽  
Jamie L. Reese ◽  
...  

The prospective PRIME trial applied real-time, objective imaging biomarkers to determine individualized retreatment needs with intravitreal aflibercept injections (IAI) among eyes with diabetic retinopathy (DR). 40 eyes with nonproliferative or proliferative DR without diabetic macular edema received monthly IAI until a DR severity scale (DRSS) level improvement of ≥2 steps was achieved. Eyes were randomized 1:1 to DRSS- or PLI- guided management. At the final 2-year visit, DRSS level was stable or improved compared to baseline in all eyes, and mean PLI decreased by 11% (p = 0.73) and 23.6% (p = 0.25) in the DRSS- and PLI-guided arms. In both arms, the percent of pro re nata (PRN) visits requiring IAI was significantly higher in year 2 versus 1 (p < 0.0001). The percent of PRN visits receiving IAI during year 1 was significantly correlated with the percent of PRN visits with IAI during year 2 (p < 0.0001). Through week 104, 77.4% of instances of DRSS level worsening in the DRSS-guided arm were preceded by or occurred alongside an increase of PLI. Overall, consistent IAI re-treatment interval requirements were observed longitudinally among individual patients. Additionally, PLI increases appeared to precede DRSS level worsening, highlighting PLI as a valuable biomarker in the management of DR.


2019 ◽  
Vol 59 (1) ◽  
pp. 241-262 ◽  
Author(s):  
Nitish Mehta ◽  
Edmund Tsui ◽  
Gregory D. Lee ◽  
Vaidehi Dedania ◽  
Yasha Modi

2021 ◽  
Vol 13 ◽  
Author(s):  
Eun Young Choi ◽  
Yae Won Park ◽  
Minyoung Lee ◽  
Min Kim ◽  
Christopher Seungkyu Lee ◽  
...  

Purpose: The aim of this study was to evaluate whether perivascular space (PVS) severity and retinal ganglion cell layer (GCL) thickness differed based on the stage of diabetic retinopathy (DR) and the cognitive status in patients with DR.Methods: A total of 81 patients with DR (51 in the non-proliferative group and 30 in the proliferative group) were included in this retrospective, cross-sectional study. PVS severity was assessed in the basal ganglia (BG) and centrum semiovale using MRI. The total cerebral small vessel disease (SVD) score was determined based on the numbers of lacunes and microbleeds and the severity of white matter hyperintensity. Optical coherence tomography was used to measure foveal and perifoveal GCL thicknesses. Cerebral SVD markers and cognitive function were compared between the groups, and correlations between the BG-PVS severity and the Mini-Mental Status Examination (MMSE) scores and GCL parameters were evaluated.Results: Patients with proliferative DR had higher BG-PVS severity (P = 0.012), higher total cerebral SVD scores (P = 0.035), reduced GCL thicknesses in the inferior (P = 0.027), superior (P = 0.046), and temporal (P = 0.038) subfields compared to patients with non-proliferative DR. In addition, the BG-PVS severity was negatively correlated with the MMSE score (P = 0.007), and the GCL thickness was negatively correlated with the BG-PVS severity (P-values &lt; 0.05 for inferior, superior, and temporal subfields).Conclusion: BG-PVS severity and retinal GCL thickness may represent novel imaging biomarkers reflecting the stage of DR and cognitive decline in diabetic patients. Furthermore, these results suggest a possible link between cerebral and retinal neurodegeneration at the clinical level.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Emma Pead ◽  
Ylenia Giarratano ◽  
Andrew J. Tatham ◽  
Miguel O. Bernabeu ◽  
Baljean Dhillon ◽  
...  

AbstractThe use of 2D alpha-shapes (α-shapes) to quantify morphological features of the retinal microvasculature could lead to imaging biomarkers for proliferative diabetic retinopathy (PDR). We tested our approach using the MESSIDOR dataset that consists of colour fundus photographs from 547 healthy individuals, 149 with mild diabetic retinopathy (DR), 239 with moderate DR, 199 pre-PDR and 53 PDR. The skeleton (centrelines) of the automatically segmented retinal vasculature was represented as an α-shape and the proposed parameters, complexity ($${Op\alpha }_{min}$$ O p α min ), spread (OpA), global shape (VS) and presence of abnormal angiogenesis (Gradα) were computed. In cross-sectional analysis, individuals with PDR had a lower $${Op\alpha }_{min}$$ O p α min , OpA and Gradα indicating a vasculature that is more complex, less spread (i.e. dense) and the presence of numerous small vessels. The results show that α-shape parameters characterise vascular abnormalities predictive of PDR (AUC 0.73; 95% CI [0.73 0.74]) and have therefore potential to reveal changes in retinal microvascular morphology.


2011 ◽  
Vol 44 (13) ◽  
pp. 59
Author(s):  
SHERRY BOSCHERT
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document